Advances in pathogenesis research and challenges in treatment development for acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 414, doi. 10.1007/s12185-024-03837-6
- By:
- Publication type:
- Article
Works matching IS 09255710 AND DT 2024 AND VI 120 AND IP 4
Results: 15
1
2
JSH practical guidelines for hematological malignancies, 2023: leukemia-3. Acute lymphoblastic leukemia/lymphoblastic lymphoma: ALL/LBL.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 394, doi. 10.1007/s12185-024-03836-7
- By:
- Publication type:
- Article
3
Pathological landscape of tumor flare reaction to epcoritamab treatment.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 467, doi. 10.1007/s12185-024-03833-w
- By:
- Publication type:
- Article
4
Bilateral development of biclonal ocular adnexal marginal zone lymphoma at a 2-year interval.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 515, doi. 10.1007/s12185-024-03821-0
- By:
- Publication type:
- Article
5
A lower initial dose of bosutinib for patients with chronic myeloid leukemia patients resistant and/or intolerant to prior therapy: a single-arm, multicenter, phase 2 trial (BOGI trial).
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 492, doi. 10.1007/s12185-024-03830-z
- By:
- Publication type:
- Article
6
Precision medicine in AML: overcoming resistance.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 439, doi. 10.1007/s12185-024-03827-8
- By:
- Publication type:
- Article
7
Molecular pathophysiology of germline mutations in acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 417, doi. 10.1007/s12185-024-03824-x
- By:
- Publication type:
- Article
8
Efficacy and safety of recombinant porcine factor VIII in Japanese patients with acquired hemophilia A.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 482, doi. 10.1007/s12185-024-03823-y
- By:
- Publication type:
- Article
9
Clinical impact of airflow obstruction after allogeneic hematopoietic stem cell transplantation.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 501, doi. 10.1007/s12185-024-03831-y
- By:
- Publication type:
- Article
10
Immunohistochemical differentiation of extramedullary acute myeloid leukemia from blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- 2024
- By:
- Publication type:
- Letter
11
Achievement of deep molecular response and treatment-free remission with asciminib treatment in CML.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 512, doi. 10.1007/s12185-024-03816-x
- By:
- Publication type:
- Article
12
Trametinib for a child with refractory Rosai–Dorfman–Destombes disease harboring a novel somatic mutation in MAP2K1.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 520, doi. 10.1007/s12185-024-03818-9
- By:
- Publication type:
- Article
13
Detection of factor XIII inhibitors in 33 patients with autoimmune factor XIII deficiency in Japan.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 472, doi. 10.1007/s12185-024-03807-y
- By:
- Publication type:
- Article
14
CAR-T cell therapy in AML: recent progress and future perspectives.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 455, doi. 10.1007/s12185-024-03809-w
- By:
- Publication type:
- Article
15
Metabolic dependencies of acute myeloid leukemia stem cells.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 4, p. 427, doi. 10.1007/s12185-024-03789-x
- By:
- Publication type:
- Article